Proteomics uncovers ICAM2 (CD102) as a novel serum biomarker of proliferative lupus nephritis
Objectives This study aimed to identify novel, non-invasive biomarkers for lupus nephritis (LN) through serum proteomics.Methods Serum proteins were detected in patients with LN and healthy control (HC) groups through liquid chromatography-tandem mass spectrometry. The key networks associated with L...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-04-01
|
| Series: | Lupus Science and Medicine |
| Online Access: | https://lupus.bmj.com/content/12/1/e001446.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|